Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…
MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…
MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…
MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…
November 11, 2024 01:00 ET | Source: Addex Therapeutics Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement…